These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4006933)

  • 1. Ceftriaxone: a three centre comparative in vitro susceptibility study.
    Emmerson AM; Lamport PA; Reeves DS; Bywater MJ; Holt HA; Wise R; Andrews J; Hall MJ
    Eur J Clin Microbiol; 1985 Apr; 4(2):142-4. PubMed ID: 4006933
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics.
    Emmerson AM; Lamport PA; Reeves DS; Bywater MJ; Holt HA; Wise R; Andrews J; Hall MJ
    Curr Med Res Opin; 1985; 9(7):480-93. PubMed ID: 3928265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
    Jarlier V; Bismuth R; Grosset J
    Pathol Biol (Paris); 1983 May; 31(5):336-42. PubMed ID: 6312393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.
    Digranes A; Benonisen E; Dibb WL
    Infection; 1982; 10(5):307-9. PubMed ID: 6293978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
    Jones RN; Barry AL; Thornsberry C
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antibacterial activity of ceftriaxone and evaluation criteria for an agar diffusion test with ceftriaxone].
    Grimm H
    Wien Med Wochenschr Suppl; 1985; 87():3-8. PubMed ID: 3856974
    [No Abstract]   [Full Text] [Related]  

  • 9. Ceftriaxone - a new broad-spectrum semisynthetic cephalosporin. In vitro activity against gram-negative bacilli sensitive and resistant to gentamicin.
    Bremner DA
    Chemotherapy; 1983; 29(4):283-8. PubMed ID: 6307605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.
    Jones RN; Barry AL
    Antimicrob Agents Chemother; 1987 May; 31(5):818-20. PubMed ID: 3606081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of ceftriaxone against clinical bacterial isolates in Nigeria.
    Obaseiki-Ebor EE; Afonya TC; Oyaide SM
    Chemotherapy; 1985; 31(2):130-7. PubMed ID: 3872779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
    Rouhan D; Le Noc P; Le Noc D
    Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activity of cefodizime and other antibiotics against pathogens recently isolated in Italy.
    Nicoletti G; Blandino G; Cocuzza G; Dainelli B; Maida A; Debbia E; Schito G
    Chemotherapy; 1996; 42(2):100-6. PubMed ID: 8697884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
    Berche P; Gaillard JL
    Ann Biol Clin (Paris); 1986; 44(6):624-7. PubMed ID: 3826779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity of cefotaxime and ceftriaxone and of imipenem, pefloxacin and norfloxacin on 13 species of bacteria].
    Rahal K
    Arch Inst Pasteur Alger; 1989; 57():213-48. PubMed ID: 2489401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO; Bryskier A; Izard D; Leclerc H
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cooperation of cefotaxime and desacetyl-cefotaxime with respect to antibacterial activity and beta-lactamase stability.
    Limbert M; Seibert G; Schrinner E
    Infection; 1982; 10(2):97-100. PubMed ID: 6284653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of cefotiam against bacteria of clinical interest.
    Watt B; Brown FV
    J Antimicrob Chemother; 1982 Nov; 10(5):391-5. PubMed ID: 6294043
    [No Abstract]   [Full Text] [Related]  

  • 20. Ceftriaxone. A new cephalosporin with aqueous humor levels effective against enterobacteriaceae.
    Axelrod JL; Newton JC; Sarakhun C; Lester RD; Merhige K; Peck RL; Francomano TJ; Sheikh MZ
    Arch Ophthalmol; 1985 Jan; 103(1):71-2. PubMed ID: 3977680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.